SECOND GENOME

Second Genome’s mission is to transform lives with medicines developed through innovative microbiome science. Second Genome has built a novel platform for microbiome drug discovery. Second Genome has completed more than 400 microbiome studies, analyzing more than 75,000 samples, for internal R&D, as well as for external partners across government, academia, pharmaceutical, nutrition and industrial companies. The team leverages its microbiome analysis platform with its partners’ specific expe... rtise to generate insightful findings that can accelerate research programs by elucidating the role of the microbiome in human health conditions, agriculture, animal health and other industries. The company has established a pipeline of therapeutic products for the treatment of inflammation and metabolic diseases.

SECOND GENOME

Social Links:

Facebook

Twitter

Industry:

Biotechnology Health Diagnostics Medical

Founded:

2009-01-01

Address:

San Francisco, California, United States

Country:

United States

Website Url:

http://www.secondgenome.com

Total Employee:

11+

Status:

Active

Contact:

9253973170

Email Addresses:

[email protected]

Total Funding:

62.5 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network

Similar Organizations

advanced-cell-diagnostics-logo

Advanced Cell Diagnostics

Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.

advaxis-logo

Advaxis

Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.

vero-biotech-logo

Vero Biotech

Vero Biotech is a biopharmaceutical company developing products to address the medical needs of patients with pulmonary, cardiac diseases.

neogenomics-logo

NeoGenomics

NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.

knopp-biosciences-logo

Knopp Biosciences

Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.

Current Advisors List

peter-gardner_image

Peter Gardner Board Member @ Second Genome
Board_member

mike-carusi_image

Mike Carusi Board Member @ Second Genome
Board_member

corey-goodman_image

Corey Goodman Board Member @ Second Genome
Board_member

jason-lettmann_image

Jason Lettmann Board Member @ Second Genome
Board_member

brad-margus_image

Brad Margus Board Member @ Second Genome
Board_member

Current Employees Featured

todd-desantis_image

Todd DeSantis
Todd DeSantis Co-Founder and V.P. of Informatics @ Second Genome
Co-Founder and V.P. of Informatics
2010-06-01

karim-dabbagh_image

Karim Dabbagh
Karim Dabbagh President and CEO @ Second Genome
President and CEO
2018-09-01

cheryl-emiliane-chow_image

Cheryl-Emiliane Chow
Cheryl-Emiliane Chow Technical Product Manager @ Second Genome
Technical Product Manager
2019-08-01

cheryl-emiliane-chow_image

Cheryl-Emiliane Chow
Cheryl-Emiliane Chow Senior Bioinformatics Scientist @ Second Genome
Senior Bioinformatics Scientist
2019-05-01

joseph-dal-porto_image

Joseph Dal Porto
Joseph Dal Porto Chief Scientific Officer @ Second Genome
Chief Scientific Officer
2022-01-01

Founder

janet-a-warrington_image

Janet A. Warrington

todd-desantis_image

Todd DeSantis

Investors List

morgenthaler-ventures_image

Newest Events participated

Participated in 3rd Annual Translational Microbiome Conference on 2017-04-11 as sponsor

Key Employee Changes

Date	New article
2022-01-19	Second Genome Appoints Joseph Dal Porto, Ph.D., as Chief Scientific Officer

Official Site Inspections

http://www.secondgenome.com Semrush global rank: 2.51 M Semrush visits lastest month: 7 K

Host Informations
Whois Informations

Loading ...